Inventor
BEATON GRAHAM
US25 patents
⚠️ This page may combine multiple inventors who share the name “BEATON GRAHAM”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
NEUROCRINE BIOSCIENCES INC
6 patentsUS9422310B2Aug 23, 2016
Gonadotropin-releasing hormone receptor antagonists and methods relating thereto
NEUROCRINE BIOSCIENCES INC14 citations92
US8952161B2Feb 10, 2015
Gonadotropin-releasing hormone receptor antagonists and methods relating thereto
NEUROCRINE BIOSCIENCES INC4 citations83
US10941159B2Mar 9, 2021
Gonadotropin-releasing hormone receptor antagonists and methods relating thereto
NEUROCRINE BIOSCIENCES INC1 citations72
US10336769B2Jul 2, 2019
Gonadotropin-releasing hormone receptor antagonists and methods relating thereto
NEUROCRINE BIOSCIENCES INC2 citations72
US11713324B2Aug 1, 2023
Gonadotropin-releasing hormone receptor antagonists and methods relating thereto
NEUROCRINE BIOSCIENCES INC0 citations62
US7393865B2Jul 1, 2008
Sleep inducing compounds and methods relating thereto
NEUROCRINE BIOSCIENCES INC0 citations30
EPIGEN BIOSCIENCES INC
6 patentsUS10570103B2Feb 25, 2020
Heterocyclic compounds useful in the treatment of disease
EPIGEN BIOSCIENCES INC3 citations70
US11427552B2Aug 30, 2022
Heterocyclic compounds useful in the treatment of disease
EPIGEN BIOSCIENCES INC0 citations59
US12234224B2Feb 25, 2025
Pyrimidine and pyridine amine compounds and usage thereof in disease treatment
EPIGEN BIOSCIENCES INC0 citations55
US11866421B2Jan 9, 2024
Pyrimidine and pyridine amine compounds and usage thereof in disease treatment
EPIGEN BIOSCIENCES INC0 citations55
US10526298B2Jan 7, 2020
Heterocyclic compounds useful in the treatment of disease
EPIGEN BIOSCIENCES INC0 citations49
US10000459B2Jun 19, 2018
Heterocyclic compounds useful in the treatment of disease
EPIGEN BIOSCIENCES INC0 citations49
CURTANA PHARMACEUTICALS INC
5 patentsUS10227333B2Mar 12, 2019
Inhibition of OLIG2 activity
CURTANA PHARMACEUTICALS INC3 citations67
US12145913B2Nov 19, 2024
Inhibition of Olig2 activity
CURTANA PHARMACEUTICALS INC0 citations55
US11242323B2Feb 8, 2022
Inhibition of OLIG2 activity
CURTANA PHARMACEUTICALS INC0 citations55
US11685722B2Jun 27, 2023
Inhibition of Olig2 activity
CURTANA PHARMACEUTICALS INC0 citations45
US11691951B2Jul 4, 2023
Inhibition of Olig2 activity
CURTANA PHARMACEUTICALS INC0 citations42
BEATON GRAHAM
4 patentsUS8084614B2Dec 27, 2011
Gonadotropin-releasing hormone receptor antagonists and methods relating thereto
BEATON GRAHAM12 citations90
US8481738B2Jul 9, 2013
Gonadotropin-releasing hormone receptor antagonists and methods relating thereto
BEATON GRAHAM6 citations82
US8507536B2Aug 13, 2013
Gonadotropin-releasing hormone receptor antagonists and methods relating thereto
BEATON GRAHAM0 citations50
US8263588B2Sep 11, 2012
Gonadotropin-releasing hormone receptor antagonists and methods relating thereto
BEATON GRAHAM0 citations50